<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112553">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01811966</url>
  </required_header>
  <id_info>
    <org_study_id>UKGMVolume</org_study_id>
    <secondary_id>UKGMVolume</secondary_id>
    <nct_id>NCT01811966</nct_id>
  </id_info>
  <brief_title>Preoperative Volume Substitution in Elective Surgery Patients</brief_title>
  <official_title>Preoperative Volume Substitution in Fasting Patients Undergoing Elective Surgery - Impact on Hemodynamic Stability During Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philipps University Marburg Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philipps University Marburg Medical Center</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative fasting can evoke a hypovolemia which may cause a hemodynamic instability
      during introduction of anesthesia.

      The purpose of this study is to test the hypothesis that a defined preoperative volume
      substitution compared to standard procedure will result in a reduced incidence of
      hemodynamic instabilities during introduction of anesthesia in elective surgery patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The preoperative fasting period often lasts longer than 2 hours as recommended by various
      national and international anesthetic guidelines. Thus, hypovolemia is more often then
      anticipated. In awake patients this condition is often masked. Introduction of anesthesia
      often leads to an unmasking of hypovolemia with a consecutive hemodynamic instability.

      Aim of the study is to test the hypothesis that a preoperative volume substitution (8 ml/kg
      RingerAcetate Solution in 15 min. prior to introduction of anesthesia) reduces possible
      hemodynamic instabilities during initiation of anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>hemodynamic instability</measure>
    <time_frame>at time of introduction of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hemodynamic instability during induction of anesthesia (0-10 min), defined as at least one of the following:
Systolic blood pressure &lt; 80 mmHg or decrease of 20% in preexistent  hypertension
Mean blood pressure &lt; 50 mmHg or decrease of 20% or &gt; 20 mmHg in preexistent hypertension
Bradycardia &lt; 45/min or decrease of 20% in preexistent bradycardia &lt; 60/min.
Tachycardia &gt; 120/min
Cardiac index &lt; 2.0 l/min/m²</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke volume index &gt; 35 ml/m2</measure>
    <time_frame>at time of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke volume variation &lt; 12 %</measure>
    <time_frame>at time of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Enddiastolic area (EDA) &gt; 10 cm2</measure>
    <time_frame>at time of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
    <description>transthoracic echocardiographic parasternal short axis enddiastolic area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inferior vana cava diameter (VCI) &gt; 15 mm</measure>
    <time_frame>at time of anesthesia</time_frame>
    <safety_issue>No</safety_issue>
    <description>transthoracic echocardiographic inferior vena cava diameter</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Hemodynamic Instability</condition>
  <condition>Hypovolemia</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>preoperative none substitution of i.v. fluids.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Volume</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preoperative substitution of a defined amount of i.v. fluids (8 ml/kg RingerAcetate solution for 15 min prior to introduction of anesthesia).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Volume</intervention_name>
    <arm_group_label>Volume</arm_group_label>
    <other_name>RingerAcetate Solution</other_name>
    <other_name>cristalloide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>none</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age  ≥ 18 years

          -  thyreoid, parathyroid or gallbladder surgery

          -  general anesthesia

        Exclusion Criteria:

          -  coronary artery disease

          -  congestive heart disease (≥ New York Heart Association (NYHA) 2)

          -  insulin dependent diabetes mellitus

          -  renal insufficiency (creatinine &gt; 2,0 mg/dl)

          -  cerebrovascular disease

          -  severe hypertension (≥ antihypertensive drugs)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Kratz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesia and Intensive Care Medicine, University Hospital Marburg, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Kratz, MD</last_name>
    <phone>0049-6421-58-70689</phone>
    <email>thomas.kratz@med.uni-marburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maik Exner, MD</last_name>
    <phone>0049-6421-58-61863</phone>
    <email>maik.exner@med.uni-marburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Marburg, Department of Anesthesia</name>
      <address>
        <city>Marburg</city>
        <zip>D-35033</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Kratz, MD</last_name>
      <phone>0049-6421-58-70689</phone>
      <email>thomas.kratz@med.uni-marburg.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Kratz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Arndt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Zoremba, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maik Exner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kai Dielmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thorsten Steinfeldt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ralph Schneider, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 20, 2013</lastchanged_date>
  <firstreceived_date>March 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Philipps University Marburg Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Thomas Kratz</investigator_full_name>
    <investigator_title>Dr. Thomas Kratz</investigator_title>
  </responsible_party>
  <keyword>preoperative volume substitution</keyword>
  <keyword>hypovolemia</keyword>
  <keyword>preoperative fasting</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypovolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
